Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Clinical

Mindfulness meditation may improve the beneficiary effects of psilocybin

Staff Writer
Staff Writer 4 years ago
Updated 2019/10/26 at 1:01 AM
Share
SHARE

Over the past few years, research studies centering on psilocybin, the active ingredient in psychedelic mushrooms, have altogether strengthened the theory on its clinical potential to treat depression and anxiety.

Now, adding to this theory, a new study has found that mindfulness meditation may improve the long-term beneficiary effects associated with psilocybin, according to the findings released in the peer-reviewed journal Scientific Reports.

The findings, as attributed by a group of researchers at the University of Zurich, were determined after a series of experiments on 39 Buddhist meditation experts, which lasted five days. The participants were ordered to undergo mindfulness meditation practices, and on the fourth day, they received either one dose of psilocybin or a placebo.

To assess the effects of psilocybin on mood, researchers issued psychometric and neurocognitive tests.

Upon examining the participants after a four-month double-blind study, researchers concluded that the group who consumed an acute dose of psilocybin saw improved meditative states, resulting in a reduction of anxiety and depressive symptoms, compared to the placebo-controlled group.

“These findings demonstrate that during acute drug effects, experienced meditators were able to remain engaged in their usual meditation practice and that psilocybin has the capacity to deepen meditative states,” wrote Lukasz Smigielski, the study’s co-author.

“Interestingly, dispositional mindfulness measured 1 day after the completion of the retreat was higher among participants who had received psilocybin than among those who had received placebo.”

The results, researchers proclaim, shines a spotlight onto a new perspective of psilocybin and its beneficiary effects on mood.

“Our findings shed light on the interplay between pharmacological and extra-pharmacological factors in psychedelic states of mind,” adds Franz Vollenweider, a researcher at the University of Zurich.

“This opens up new therapeutic avenues, for example for the treatment of depression, which is often accompanied by increased self-focus and social deficits.”

You Might Also Like

Study boasts MDMA-assisted therapy for PTSD patients

How the brain is organized is revealed by the largest genetic study of brain structure to date

Study investigates the ethical implications of combining the analysis of ancient DNA and data from private genetic databases

New study reveals positive results from postpartum depression treatment Zuranolone

New study explores magic mushrooms for anorexia nervosa psychopathology

TAGGED: meditation, mindfulness, psilocybin
Staff Writer October 25, 2019
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article Women less likely than men to author invited commentaries in scientific journals
Next Article Frontotemporal dementia linked to an overactive immune system function

Recommended

Clinical

Study boasts MDMA-assisted therapy for PTSD patients

1 Min Read
Clinical

How the brain is organized is revealed by the largest genetic study of brain structure to date

2 Min Read
Clinical

Study investigates the ethical implications of combining the analysis of ancient DNA and data from private genetic databases

3 Min Read
Clinical

New study reveals positive results from postpartum depression treatment Zuranolone

2 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • The Editor
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?